Clinical Trials in New York

Showing 16681-16700 of 22,668 trials

Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy

NCT01522235

The purpose of the study is to see if administering intravenous immune globulin (IVIG) (putting immune globulin directly into your blood) helps to improve the symptoms of orthostatic hypotension (sudden fall in blood pressure when a person stands up) and quality of life in men and women who have autoimmune autonomic ganglionopathy (AAG).

Autoimmune Autonomic Ganglionopathy (AAG)

Beth Israel Deaconess Medical Center6 participantsStarted Feb 2012

Bethesda, Maryland, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +3 more locations

UNKNOWNNA< 1 mile

Optimizing Integration of CPR Feedback Technology With CPR Coaching for Cardiac Arrest

NCT03204162

There is significant data showing that the quality of CPR performed is quite poor. Recent studies have shown that when real-time visual corrective feedback is available to CPR providers, quality (compression depth and rate) improves. Pilot work at John's Hopkins Children's Hospital indicates that providing a CPR Coach whose role it is to provide real-time coaching during cardiac arrest, further improves the quality of CPR. This study will assess the impact of a CPR Coach for improving CPR quality and CPR perception in a team of healthcare providers during simulated CPA.

Cardiopulmonary Resuscitation

KidSIM Simulation Program180 participantsStarted Sep 2017

Birmingham, Alabama, United States • New York, New York, United States • Providence, Rhode Island, United States +2 more locations

Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy

Optimizing Integration of CPR Feedback Technology With CPR Coaching for Cardiac Arrest

Find Trials by Condition in New York

Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients

DNA Analysis in Predicting Response to Antibody Therapy in Patients With Follicular Lymphoma Treated on Clinical Trials CALGB-50402 or CALGB-50701

A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome

Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings

A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.

To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)

Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Large Diameter Advanta™ V12 Covered Stent Trial for Coarctation of the Aorta